Polyclonal Rabbit anti‑Human CDCA8 / Borealin Antibody (Biotin, aa200‑250, IF, WB) LS‑C143117
Polyclonal Rabbit anti‑Human CDCA8 / Borealin Antibody (Biotin, aa200‑250, IF, WB) LS‑C143117
Antibody:
CDCA8 / Borealin Rabbit anti-Human Polyclonal (aa200-250) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
CDCA8 / Borealin Rabbit anti-Human Polyclonal (aa200-250) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Borealin antibody LS-C143117 is a biotin-conjugated rabbit polyclonal antibody to human Borealin (CDCA8) (aa200-250). Validated for ICC, IF and WB.
Target
Human CDCA8 / Borealin
Synonyms
CDCA8 | Borealin | Dasra B | Dasra-B | DasraB | HDasra-B | PESCRG3 | BOR | MESRGP
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
DY650,
DY488,
DY550.
Purification
Immunoaffinity purified
Immunogen
Synthetic peptide made to an internal portion of the human protein (within residues 200-250). [Swiss-Prot# Q53HL2]. Percent identity by BLAST analysis: Mouse, Rat (92%).
Applications
- ICC
- Immunofluorescence
- Western blot (2 µg/ml)
- Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, 0.05% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
ICC, Western blot, Immunoprecipitation
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Species:
Human, Mouse, Rat
Applications:
Immunofluorescence, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/27/2024